COPD: A Multi-center Supervised Tele-rehabilitation Study
COPDMUST
Chronic Obstructive Pulmonary Disease: A Multi-center Supervised Tele-rehabilitation Study
1 other identifier
interventional
360
1 country
1
Brief Summary
Chronic obstructive pulmonary disease(COPD) patients could benefit from pulmonary rehabilitation(PR) in better managing of the disease and its symptoms and in avoiding future relapses and hospitalizations. However, due to a large number of drop outs from PR, lack of professionals, and the (Corona Virus Disease 2019) COVID-19 epidemic, the PR has been underutilized, leading to a need for investigation of updated forms. The study aims to investigate the effects of a home-based PR program using minimal accessories, facilitated with wearable activity trackers and smartphones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable chronic-obstructive-pulmonary-disease
Started Nov 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 6, 2023
CompletedFirst Posted
Study publicly available on registry
October 16, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedOctober 16, 2023
October 1, 2023
9 months
August 6, 2023
October 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
6-minute walk distance (6MWD)
6-minute walk distance
8 weeks; 20 weeks
Secondary Outcomes (13)
pulmonary function
8 weeks; 20 weeks
pulmonary function
8 weeks; 20 weeks
pulmonary function
8 weeks; 20 weeks
pulmonary function
8 weeks; 20 weeks
pulmonary function
8 weeks; 20 weeks
- +8 more secondary outcomes
Study Arms (2)
home-based telerehabilitation
EXPERIMENTALRemotely supervised telerehabilitation at home will be conducted for 8 weeks, comprising lower limb aerobic training, individualized strength training and respiratory training exercises.
center-based traditional rehabilitation
ACTIVE COMPARATORParticipants will undertake an aerobic, strength and respiratory training program of similar intensity and duration to the home-based program, at their site of recruitment.
Interventions
Participants will download the web application in their smartphones in the hospital's outpatient clinic and learn to use the sports wristwatch. Remotely supervised telerehabilitation at home will be conducted for 8 weeks, comprising lower limb aerobic training, individualized strength training and respiratory training exercises. The initial aerobic exercise prescription for walking will be set at 80% of the speed walked during a 6-minute walk test (6MWT) and progressed each 4-week according to patient assessments. Resistance training for the arms and legs will utilize elastic bands, while respiratory training will utilize portable breathing trainer. During each training session, participants will be asked to follow the videos in the web application, wearing the sports wristwatch recording their exercise intensity. At the end of every training session, training data could be uploaded to the web platform automatically, which will be checked by staff in hospital.
Participants will undertake an aerobic, strength and respiratory training program of similar intensity and duration to the home-based program, at their site of recruitment. The initial aerobic exercise prescription for cycling will be set at 60% of the peak oxygen uptake (VO2) on a cardiopulmonary exercise test (CPET). Resistance training and respiratory training are similar to the telerehabilitation group.
Eligibility Criteria
You may not qualify if:
- Certain comorbidities (e.g. unstable coronary complications)
- Severe cognitive disabilities (e.g. dementia)
- Inability to cope with the program because of severe hearing or visual disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
China-Japan Friendship hospital
Beijing, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Shiwei Qumu, Dr
China-Japan Friendship Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
August 6, 2023
First Posted
October 16, 2023
Study Start
November 1, 2023
Primary Completion
August 1, 2024
Study Completion
December 1, 2024
Last Updated
October 16, 2023
Record last verified: 2023-10